Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-0797
Abstract: Introduction Recurrent and metastatic pheochromocytoma (PCC) are rare advanced endocrine neoplasms with limited treatment options. Insight into the pathogenic molecular alterations in patients with advanced PCC can provide therapeutic options for precisely targeting dysregulated pathways.… read more here.
Keywords: fusion; braf; pcc; pheochromocytomatosis ... See more keywords